The Trump administration is reportedly moving forward with a $2.8 billion munitions sale to Israel, according to a U.S. official familiar with the matter. The proposed package includes a significant quantity of high-payload weaponry, specifically 20,000 MK 84 bombs and 20,000 BLU-117 bombs. These munitions are known for their high destructive capacity, with the MK 84 being a 2,000-pound general-purpose bomb.

This information, first reported by Reuters, indicates that the administration has already initiated the informal notification process with relevant congressional committees. These committees typically review large-scale foreign military sales before they are formally announced. The official who provided the details spoke on the condition of anonymity, as the details of the sale have not been publicly finalized or confirmed by the White House or the Department of Defense.

While the report outlines the scale and composition of the munitions, it does not specify the intended timeline for delivery or the specific strategic objectives behind the sale. The move comes amid ongoing regional tensions and follows a history of U.S. military support for Israel. As of now, there has been no official statement from the Trump administration confirming the specific figures or the status of the congressional review process. The sale remains subject to legislative oversight, and congressional members may raise questions regarding the impact of such a large transfer of heavy munitions on regional stability.